2m 2m 2m 2m 2m 2m 2m
ABCELLERA BIOLOG (ABCL)
NASDAQ
$11.28-$0.04 (-0.34%)
Price as of Aug 21, 2026 7:59 PM EDT- $3.7BMarket Cap
- 157.86%1-Year Change
- BiotechnologyIndustry
ABCELLERA BIOLOG (ABCL)
$11.28-$0.04 (-0.34%)
ABCL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $11.32 | ||
Change | -$0.25 (-2.16%) | ||
Open | $11.57 | ||
High | $11.80 | ||
Low | $11.14 | ||
Previous Close | $11.57 | ||
Volume | 4,553,044 | ||
30-Day Average Volume | 9,306,184 | ||
1-Week Change | -0.53% | ||
1-Month Change | 89.61% | ||
1-Year Change | 157.86% | ||
3-Year Change | 102.87% | ||
5-Year Change | -29.43% | ||
Fundamentals | |||
Shares Outstanding | 324.0M | ||
Total Assets | $1.3B | ||
Market Cap | $3.7B | ||
Enterprise Value | $3.6B | ||
Period: QTR TTM FY | |||
Revenue | $3.9M | ||
Net Income | -$55.4M | ||
Free Cash Flow | $23.8M | ||
EBIT | -$58.9M | ||
EBITDA | -$58.0M | ||
Net Working Capital | $626.0M | ||
EPS | -$0.18 | ||
Enterprise Value/EBITDA | -62 | ||
Enterprise Value/Revenue | 925 | ||
P/B | 4 | ||
P/E | -63 | ||
PEG | 2 | ||
Price/Free Cash Flow | 154 | ||
Price/Operating Cash Flow | 142 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue